NUH will soon undergo a routine GCP systems inspection by the MHRA (Medicines and Healthcare Products Regulatory Agency). This will take place during the last week of February and is coordinated by the R&D
department. The investigators who will be interviewed have already been notified and R&D has been working closely with the research teams in order to prepare for a successful inspection.
During the month of February, R&D staff will be dedicating the bulk of their time to preparation for the inspection visit. Many R&D staff will be interviewed by the inspectors on the systems and process which
have been put in place. We will therefore not be in a position to conduct any governance reviews until after the end of the inspection. Thank you for your consideration and cooperation.